Gastric Cancer

, Volume 13, Issue 3, pp 170–176 | Cite as

High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

  • Hideaki Shimada
  • Nobuhiro Takiguchi
  • Osamu Kainuma
  • Hiroaki Soda
  • Atsushi Ikeda
  • Akihiro Cho
  • Akinari Miyazaki
  • Hisashi Gunji
  • Hiroshi Yamamoto
  • Matsuo Nagata
Original Article

Abstract

Background

The neutrophil-lymphocyte ratio (NLR) reflects inflammatory status. An elevated NLR has been reported to be a prognostic indicator in some malignant tumors. The aim of this study was to evaluate the clinical significance of the preoperative NLR in patients with primary gastric cancer.

Methods

A total of 709 men and 319 women, with a mean age of 64.4 years, who underwent gastrectomy were included. The numbers of patients in each pathological stage were as follows: stage I, 584; stage II, 132; stage III, 153; and stage IV, 159. The mean NLR was 2.62 ± 1.68. A total of 127 patients (12.4%) with an NLR of 4.0 or more were classified as high NLR individuals in this study. The prognostic significance of a high NLR, together with various clinicopathological factors, was evaluated by multivariate analysis.

Results

The 5-year survival of patients with a high NLR was significantly worse than that of patients with a low NLR (57% vs 82%, P < 0.001). Univariate and multivariate analyses of clinicopathological factors affecting survival revealed that high NLR, depth of tumor, positive lymph nodes, distant metastasis, peritoneal metastasis, poorly differentiated type, and high platelet count were significant risk factors for reduced survival. On multivariate analysis, after adjusting for tumor stage, a high NLR was an independent risk factor for reduced survival (P = 0.003; adjusted hazard ratio, 1.845; 95% confidence interval, 1.236–2.747).

Conclusion

A high preoperative NLR may be a convenient biomarker to identify patients with a poor prognosis after resection for primary gastric cancer.

Key words

Neutrophil-lymphocyte ratio Gastric cancer Survival 

References

  1. 1.
    Nakajima K, Suzuki T, Shimada H, Hayashi H, Takeda A, Ochiai T. Detection of preoperative serum anti-p53 antibodies in gastric cancer. Tumour Biol 1999;20:147–152.CrossRefPubMedGoogle Scholar
  2. 2.
    Nakajima K, Ochiai T, Suzuki T, Shimada H, Hayashi H, Yasumoto A, et al. Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients. Tumour Biol 1998;19:464–469.CrossRefPubMedGoogle Scholar
  3. 3.
    Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.CrossRefPubMedGoogle Scholar
  4. 4.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539–545.CrossRefPubMedGoogle Scholar
  5. 5.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Aoki T, et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2003;83:248–252.CrossRefPubMedGoogle Scholar
  6. 6.
    Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 2004;198:737–741.CrossRefPubMedGoogle Scholar
  7. 7.
    Ietomi K. A study on the role of granulocytes in carcinomabearing hosts — G/L ratio as a new host indicator (in Japanese). Nippon Gan Chiryo Gakkai Shi 1990;25:662–671.PubMedGoogle Scholar
  8. 8.
    Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T, Sonoda M. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 1995;34:69–73.CrossRefPubMedGoogle Scholar
  9. 9.
    Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–184.CrossRefPubMedGoogle Scholar
  10. 10.
    Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after completeresection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009;137:425–428.CrossRefPubMedGoogle Scholar
  11. 11.
    Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, et al. Elevated preoperative neutrophil-to-lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55–60.PubMedGoogle Scholar
  12. 12.
    Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008;32:1757–1762.CrossRefPubMedGoogle Scholar
  13. 13.
    Shau HY, Kim A. Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 1988;141:4395–4402.PubMedGoogle Scholar
  14. 14.
    Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol 1998;124:329–334.CrossRefPubMedGoogle Scholar
  15. 15.
    Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215–220.CrossRefPubMedGoogle Scholar
  16. 16.
    Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep 2000;7:1157–1161.PubMedGoogle Scholar
  17. 17.
    Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, et al. Effects of gender on white blood cell populations and neutrophillymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci 2007;22:104–108.CrossRefGoogle Scholar
  18. 18.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma — 2nd English edition —. Gastric Cancer 1998;1:10–24.CrossRefPubMedGoogle Scholar
  19. 19.
    Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organization LC00-03. Eur J Cancer 2009;45:1950–1958.CrossRefPubMedGoogle Scholar
  20. 20.
    Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 2006;24:1997–2005.CrossRefPubMedGoogle Scholar
  21. 21.
    Donskov F, Hokland M, Marcussen N, Torp Madsen HH, von der Maase H. Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma-results from a randomised phase II trial. Br J Cancer 2006;94:218–226.CrossRefPubMedGoogle Scholar
  22. 22.
    Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer stage IV melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 2007;25:1562–1569.CrossRefPubMedGoogle Scholar
  23. 23.
    Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287–291.CrossRefPubMedGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2010

Authors and Affiliations

  • Hideaki Shimada
    • 1
    • 2
  • Nobuhiro Takiguchi
    • 1
  • Osamu Kainuma
    • 1
  • Hiroaki Soda
    • 1
  • Atsushi Ikeda
    • 1
  • Akihiro Cho
    • 1
  • Akinari Miyazaki
    • 1
  • Hisashi Gunji
    • 1
  • Hiroshi Yamamoto
    • 1
  • Matsuo Nagata
    • 1
  1. 1.Department of Gastroenterological SurgeryChiba Cancer CenterChibaJapan
  2. 2.Department of SurgeryToho University School of MedicineTokyoJapan

Personalised recommendations